Literature DB >> 9669946

HIV treatment failure: testing for HIV resistance in clinical practice.

L Perrin1, A Telenti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9669946     DOI： 10.1126/science.280.5371.1871

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  43 in total

Review 1.  Monitoring patients with HIV disease.

Authors:  M Helbert; J Breuer
Journal:  J Clin Pathol       Date:  2000-04       Impact factor: 3.411

2.  Production of resistant HIV mutants during antiretroviral therapy.

Authors:  R M Ribeiro; S Bonhoeffer
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

3.  HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use.

Authors:  Alexandra Trkola; Shawn E Kuhmann; Julie M Strizki; Elizabeth Maxwell; Tom Ketas; Tom Morgan; Pavel Pugach; Serena Xu; Lisa Wojcik; Jayaram Tagat; Anandan Palani; Sherry Shapiro; John W Clader; Stuart McCombie; Gregory R Reyes; Bahige M Baroudy; John P Moore
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-08       Impact factor: 11.205

4.  Assessing the cost-effectiveness of pharmacogenomics.

Authors:  D L Veenstra; M K Higashi; K A Phillips
Journal:  AAPS PharmSci       Date:  2000

5.  Preparing social workers to address HIV/AIDS prevention and detection: implications for professional training and education.

Authors:  Michael S Wolf; Christopher G Mitchell
Journal:  J Community Health       Date:  2002-06

6.  Sensitive genetic screen for protease activity based on a cyclic AMP signaling cascade in Escherichia coli.

Authors:  N Dautin; G Karimova; A Ullmann; D Ladant
Journal:  J Bacteriol       Date:  2000-12       Impact factor: 3.490

7.  Controlling the Evolution of Resistance.

Authors:  Rutao Luo; Lamont Cannon; Jason Hernandez; Michael J Piovoso; Ryan Zurakowski
Journal:  J Process Control       Date:  2011-03-01       Impact factor: 3.666

8.  Novel enzyme-linked minisequence assay for genotypic analysis of human immunodeficiency virus type 1 drug resistance.

Authors:  Wataru Sugiura; Kazunori Shimada; Masakazu Matsuda; Tomoko Chiba; Lay Myint; Aiko Okano; Kaneo Yamada
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

9.  Geno2pheno: Estimating phenotypic drug resistance from HIV-1 genotypes.

Authors:  Niko Beerenwinkel; Martin Däumer; Mark Oette; Klaus Korn; Daniel Hoffmann; Rolf Kaiser; Thomas Lengauer; Joachim Selbig; Hauke Walter
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

10.  The human immunodeficiency virus-1 protease inhibitor nelfinavir impairs proteasome activity and inhibits the proliferation of multiple myeloma cells in vitro and in vivo.

Authors:  Camille Bono; Lionel Karlin; Stephanie Harel; Enguerran Mouly; Sylvaine Labaume; Lionel Galicier; Sébastien Apcher; Hélène Sauvageon; Jean-Paul Fermand; Jean-Christophe Bories; Bertrand Arnulf
Journal:  Haematologica       Date:  2012-01-22       Impact factor: 9.941
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.